Phagos Biotech
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $32M
Investors
- 10
About Phagos Biotech
Based in Paris, France, and founded in 2021, Phagos Biotech operates as a biotechnology company that focuses on manufacturing antibacterial medicines using bacteriophage. The biotechnology company is working on a solution by cultivating bacteria’s natural predator, the bacteriophage. Phagos can overcome incurable and deadly infectious diseases. If used appropriately, bacteriophage can offer a sustainable and efficient alternative to antibiotics.
Who invested in Phagos Biotech
10 investors across 2 rounds
See all investors in Phagos Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phagos Biotech
Who invested in Phagos Biotech?
Phagos Biotech has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phagos Biotech raised?
Phagos Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Phagos Biotech last raise money?
Phagos Biotech's most recent round on record is a Series A, in Oct 2025.
What does Phagos Biotech do?
Based in Paris, France, and founded in 2021, Phagos Biotech operates as a biotechnology company that focuses on manufacturing antibacterial medicines using bacteriophage.
Where is Phagos Biotech headquartered?
Phagos Biotech is headquartered in Suresnes, France.
Which VCs invest in companies like Phagos Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Phagos Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Phagos Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.